Leicester Diabetes Centre has a national and international reputation for clinical care underpinned by innovative and world leading clinical research.
Leicesester Diabetes Centre has run a wide range of research studies that looked at the areas of early detection, prevention, structured education, and new therapies along with teaching and training for both patients and health care professionals. The results of these studies have had an impact on local NHS policies, Department of Health programmes and NICE Guidance.
Below is selection of our work, if you would like to get involved in research please click below:
Headline Studies
Active Studies
An efficacy study exploring the optimisation of sleep and the reduction of sedentary behaviour in those living with type 2 diabetes mellitus - Step up 2 Sleep.
We will use the information gathered in this study to design and test an intervention which aims to improve the health and well-being of people with multiple long-term health conditions, and those who care for them, equally.
The impact of a holistic multifactorial management intervention in adults with early-onset type 2 diabetes.
NIHR Global Health Research Group on collaborative care for cardiometabolic disease in Africa.
The impact of a fat-rich preload before a carbohydrate-rich meal on glucose homeostasis in patients without diabetes after sleeve gastrectomy: A proof-of-concept, randomised, open-label, crossover study.
The Anglo-Danish-Dutch Study of Intensive Treatment In People with Screen Detected Diabetes in Primary Care (ADDITION study).
The effect of increased sodium intake with a carbohydrate-rich meal on glucose homeostasis in subjects without diabetes after bariatric surgery.
The effect of acute aerobic exercise on the time spent in hypoglycaemia after Roux-en-Y gastric bypass.
The effect of Canagliflozin 300mg in subjects without diabetes after bariatric surgery, on glucose homeostasis: A randomised cross-over study.
Impact of exercise training in combination with dapagliflozin on physical function in adults with type 2 diabetes mellitus.
Research into new drug (tirzepatide) for type 2 diabetes and heart disease, compared to dulaglutide.
Comparing Tirzepatide versus Semaglutide add-on therapy to Metformin in people with Type 2 diabetes
Effectiveness and cost of integrating a protocol with use of Liraglutide into an obesity service
Past Studies
A trial to investigate the effect of structured education on people at high risk of cardiovascular disease